March 15, 2013 at 17:59 PM EDT
United Therapeutics Near Top Of Strong Industry Group
Biotech stock United Therapeutics (UTHR) has emerged as a leading member of an industry group that has been among the best performers over the past two years. The stock boasts a best-possible 99 IBD Composite Rating, ranking it alongside stalwarts such as Celgene (CELG) at the top of IBD's Medical-Biomedical/Biotech industry group. As of Friday, the group was ranked No. 16 out of 197. United Therapeutics, which produces drugs to treat
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here